GSK plc vs New Era Energy & Digital Inc. Common Stock — how do they compare? GSK plc trades at $46.65 (market cap $91.88B), while New Era Energy & Digital Inc. Common Stock trades at $4.7 (market cap $583.45M). The key difference: GSK plc is far larger — about 157.5× New Era Energy & Digital Inc. Common Stock's market cap, and GSK plc pays a 3.9% dividend while New Era Energy & Digital Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and New Era Energy & Digital Inc. Common Stock for 0 Days on average.
| GSK | NUAI | |
|---|---|---|
Market Cap | $91.88B | $583.45M |
Volume | 7,730,529 | 17,217,412 |
Sector | Health | Technology |
52-Week High | $61.18 | $8.06 |
52-Week Low | $43.24 | $2.35 |
Typical Hold Time | 93 Days | 0 Days |
Enterprise Value | $111.88B | $528.80M |
Dividend Yield | 3.9% | — |
Signals from Pluang's Aura AI — not financial advice
GSK trades at $46.45, down 1.21% with bearish technical signals. The company shows strong fundamentals with revenue growth to $32.67B in 2025 and consistent earnings beats. Valuation metrics appear reasonable with P/E of 14.89 and EV/EBITDA of 8.75. Recent developments include strategic oncology partnerships and a $750M cancer therapy acquisition, positioning for long-term growth despite near-term technical weakness.
GSK presents a mixed outlook with strong profitability and pipeline expansion offset by technical bearishness and HIV patent concerns. The company's 29.73% ROE and recent earnings outperformance support investment appeal, while the bearish moving average signal and competitive pressures warrant caution. Analyst consensus leans hold with 55% neutral rating, suggesting balanced risk-reward for long-term investors.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →New Era Energy & Digital develops large-scale data centers in energy-rich U.S. markets for AI training and inference workloads. Its Texas Critical Data Centers project in the Permian Basin combines modular deployment with flexible power solutions.
Read more on NUAI →